Thank drug patents for life-saving breakthroughs. Why weakening laws will stifle innovation
-----
In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in the United States. Just days prior, the Food and Drug Administration tentatively approved another generic version of Victoza made by Hikma Pharmaceuticals.Victoza is one of the first GLP-1 drugs — the class of wildly popular diabetes and obesity treatments that includes Ozempic and Wegovy — to go off-patent.
Within just a couple of years, GLP-1 (glucagon-like
